Gonadotrophin-releasing hormone antagonist regimen versus agonist regimen among normal ovarian responders: a systematic review and meta-analysis
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
This systematic review and meta-analysis compared the efficacy and safety of gonadotrophin-releasing hormone antagonist (GnRH-ant) versus GnRH agonist (GnRH-a) regimens in women with a normal ovarian response undergoing controlled ovarian stimulation. PubMed, Embase, Cochrane Library, CNKI, VIP, and Wanfang were searched from inception to April 30, 2024. Randomized controlled trials were independently screened, appraised for risk of bias, and synthesized using meta-analysis. Eight RCTs involving 1,841 participants were included. Compared with GnRH-a, GnRH-ant was associated with fewer retrieved oocytes (WMD -0.77, 95% CI -1.35 to -0.20; P=0.009) and a lower implantation rate (RR 0.75, 95% CI 0.60 to 0.93; P=0.009), but required less total gonadotrophin (WMD -389.65; P
Fields of Study & Subjects
Reproductive Biology and Fertility
Ovarian function and disorders
Reproductive Health and Technologies
Publication details
- Journal / source
- African Journal of Reproductive Health
- Volume
- 30
- Issue
- 6
- Pages
- 125–139
- Publication date
- 31 March 2026
- Language
- EN